James Doroshow
Senior Investigator · Clinical Center at the National Institutes of Health
Credentials: · ·
History
Medical Oncology
Harvard College
Research
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Cancer Research · 2012 · 1,844 citations
Cancer Research · 2012 · 727 citations
Journal of Clinical Investigation · 1980 · First of 3 authors · 658 citations
83 papers · 2 as a fellow
81 papers
- LL
64 papers
- AC
Alice Chen
59 papers
- GS
57 papers
54 papers
39 papers · 3 as a fellow
- SS
32 papers
Grants
- 1992–2008
City of Hope Clinical Oncology Career Research Development Program
National Cancer Institute · K12
Contact PI · $3.7M · Beckman Research Institute/City of Hope
- 1994–2008
Phase I Molecular and Clincal Pharmacodynamic Trials
National Cancer Institute · U01
Contact PI · $2.6M · Beckman Research Institute/City of Hope
- 2003–2004
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $182.9K · University of Southern California
- 1988–2004
City of Hope Southwest Oncology Group Clinical Trials
National Cancer Institute · U10
Contact PI · $2M · Beckman Research Institute/City of Hope
Clinical trials
- 2018–2026
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
Principal investigator · Recruiting · Phase 1
National Cancer Institute (NCI)
- 2015–2026
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Principal investigator · Recruiting
National Cancer Institute LAO
- 2015–2025
Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors
Principal investigator · Completed · Phase 1
National Cancer Institute (NCI)
- 2012–2025
FdCyd and THU for Advanced Solid Tumors
Principal investigator · Completed · Phase 1
National Cancer Institute (NCI)